# Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism

> **NCT04648969** · PHASE2 · COMPLETED · sponsor: **Stephanie B. Seminara, MD** · enrollment: 18 (actual)

## Conditions studied

- Hypogonadotropic Hypogonadism

## Interventions

- **DRUG:** kisspeptin 112-121
- **DRUG:** GnRH

## Key facts

- **NCT ID:** NCT04648969
- **Lead sponsor:** Stephanie B. Seminara, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-03
- **Primary completion:** 2025-08-31
- **Final completion:** 2025-08-31
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2026-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04648969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04648969, "Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04648969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*